AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Snufin G 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Ridgecure Pharma

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Snufin G 2mg/500mg Tablet SR

Diabexe Duo 2mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose. Diabexe Duo should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, increasing the risk of kidney complications, vision loss, neuropathy, and limb impairment. This medication is part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as recommended by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available fast-acting glucose sources (e.g., sugary snacks, fruit juice) are essential. Alcohol consumption should be minimized due to its hypoglycemic effect. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.

Primary Ingredients of Snufin G 2mg/500mg Tablet SR

No information provided. Please provide the text you wish me to rephrase.

Uses of Snufin G 2mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Snufin G 2mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Snufin G 2mg/500mg Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Snufin G 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Snufin G 2mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Snufin G 2mg/500mg Tablet SR whole; do not break, crush, or chew it. Administer this medication with food.

How Snufin G 2mg/500mg Tablet SR works:

Snufin G SR tablets (2mg glimepiride/500mg metformin) combine two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Snufin G 2mg/500mg sustained-release tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Prolonged-release Snufin G 2mg/500mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Prolonged-release Snufin G tablets (2mg/500mg) are contraindicated for breastfeeding mothers due to the potential for infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Snufin G 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Snufin G 2mg/500mg SR tablets are contraindicated in patients with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Snufin G 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Individuals with mild to moderate liver disease should begin with a reduced dose; however, its use is contraindicated in those with severe hepatic dysfunction. Physician consultation is advised.

What if you forget to take Snufin G 2mg/500mg Tablet SR :

Should you forget a dose of Snufin G 2mg/500mg Extended-Release Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Snufin G 2mg/500mg Tablet SR

LabelValue
Developing Good Habits No.
Treatment Category Diabetes Management

FAQs on Snufin G 2mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Snufin G 2mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Snufin G 2mg/500mg Tablet SR and seek immediate medical attention.
Snufin G 2mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
Snufin G 2mg/500mg SR Tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can result in vitamin B12 deficiency.
Prolonged use of Snufin G 2mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Snufin G 2mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Snufin G 2mg/500mg SR tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Snufin G 2mg/500mg Tablet...
41
MRP 47
12% off